- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2008
- Public Summary Document (PSD) July 2008 PBAC Meeting - PDF
Infliximab – July 2008
Infliximab, powder for IV infusion, 100 mg, Remicade®, July 2008
Last updated
14 November 2008